Vaso corporation, a diversified medical technology company currently trading on the otcqx market, to list on nasdaq via spac merger

Business combination with achari ventures holdings corp. i is expected to be completed in first quarter of 2024 merger with achari ventures holdings corp. i (nasdaq:avhi) expected to improve capital market access for existing and prospective investors of vaso corporation (otcqx:vaso). the transaction values vaso at a pro forma equity value of approximately $176 million at $10 per share.
AVHI Ratings Summary
AVHI Quant Ranking